Suppr超能文献

中性粒细胞与淋巴细胞比值预测心脏再同步治疗反应。

Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy.

机构信息

Department of Cardiology, Kocaeli University Medical Faculty, Kocaeli, Turkey.

出版信息

Med Sci Monit. 2013 May 17;19:373-7. doi: 10.12659/MSM.883915.

Abstract

BACKGROUND

Neutrophil-to-lymphocyte (N/L) ratio has been associated with adverse outcomes in patients with acute coronary syndromes and increased risk for long-term mortality in patients with acute decompensated heart failure. We aimed to investigate the prognostic value of neutrophil-to-lymphocyte ratio on response to cardiac resynchronization therapy (CRT).

MATERIAL AND METHODS

Seventy consecutive patients (mean age 58 ± 13 years; 40 men) undergoing CRT were included in the study. Hematological and echocardiographic parameters were measured before and 6 months after CRT. Echocardiographic response to CRT was defined as a ≥ 15% reduction in left ventricular end-systolic volume at 6-month follow-up.

RESULTS

After 6 months of CRT, 49 (70%) patients were responders. After 6 months, left ventricular ejection fraction (LVEF) had significantly increased, from 21 ± 7% to 34 ± 11% in responder patients (p = 0.001). N/L ratio decreased significantly, from 2.4 ± 1 to 2.1 ± 0.7 in responders (p = 0.04). In multivariate analysis, significant associates of echocardiographic response to CRT was evaluated adjusting for age, etiology of cardiomyopathy, baseline LVEF, New York Heart Association functional class, C-reactive protein, and baseline N/L ratio. Baseline N/L ratio was the only predictor of response to CRT (OR 1.506, 95% CI, 1.011-2.243, p = 0.035).

CONCLUSIONS

N/L ratio at baseline could help to identify patients with response to CRT.

摘要

背景

中性粒细胞与淋巴细胞比值(N/L)与急性冠状动脉综合征患者的不良预后相关,并且与急性失代偿性心力衰竭患者的长期死亡率升高相关。我们旨在研究中性粒细胞与淋巴细胞比值对心脏再同步化治疗(CRT)反应的预测价值。

材料和方法

本研究纳入了 70 例连续接受 CRT 的患者(平均年龄 58±13 岁,40 名男性)。在 CRT 前后测量血液学和超声心动图参数。CRT 反应定义为 6 个月随访时左心室收缩末期容积减少≥15%。

结果

CRT 后 6 个月,49 例(70%)患者为应答者。CRT 后 6 个月,左心室射血分数(LVEF)从应答者的 21±7%显著增加至 34±11%(p=0.001)。N/L 比值从 2.4±1 显著降低至 2.1±0.7(p=0.04)。在多变量分析中,通过调整年龄、心肌病病因、基线 LVEF、纽约心脏协会功能分级、C 反应蛋白和基线 N/L 比值,评估 CRT 超声心动图反应的相关因素。基线 N/L 比值是 CRT 反应的唯一预测因素(OR 1.506,95%CI,1.011-2.243,p=0.035)。

结论

基线 N/L 比值有助于识别对 CRT 有反应的患者。

相似文献

1
Neutrophil-to-lymphocyte ratio predicts response to cardiac resynchronization therapy.
Med Sci Monit. 2013 May 17;19:373-7. doi: 10.12659/MSM.883915.
2
Association between red blood cell distribution width and response to cardiac resynchronization therapy.
J Interv Card Electrophysiol. 2012 Nov;35(2):215-8. doi: 10.1007/s10840-012-9694-1. Epub 2012 Jun 12.
4
Number of leads with fragmented QRS predicts response to cardiac resynchronization therapy.
Clin Cardiol. 2013 Jan;36(1):36-9. doi: 10.1002/clc.22061. Epub 2012 Oct 18.
5
Systolic aortic root motion predicts response to cardiac resynchronization therapy.
Pacing Clin Electrophysiol. 2019 Nov;42(11):1471-1476. doi: 10.1111/pace.13792. Epub 2019 Sep 3.
8
The effect of iron deficiency on cardiac resynchronization therapy: results from the RIDE-CRT Study.
ESC Heart Fail. 2020 Jun;7(3):1072-1084. doi: 10.1002/ehf2.12675. Epub 2020 Mar 18.
9
Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
Heart Rhythm. 2013 Aug;10(8):1136-43. doi: 10.1016/j.hrthm.2013.04.013. Epub 2013 May 25.

本文引用的文献

1
Number of leads with fragmented QRS predicts response to cardiac resynchronization therapy.
Clin Cardiol. 2013 Jan;36(1):36-9. doi: 10.1002/clc.22061. Epub 2012 Oct 18.
4
Nonechocardiographic imaging in evaluation for cardiac resynchronization therapy.
Circ Cardiovasc Imaging. 2011 May;4(3):334-43. doi: 10.1161/CIRCIMAGING.111.963504.
6
Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy.
Eur J Heart Fail. 2011 Jan;13(1):43-51. doi: 10.1093/eurjhf/hfq182. Epub 2010 Nov 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验